2/14
09:15 am
bntc
Benitec Biopharma Announces Acceptance of Late- Breaking Oral Abstract for the BB-301 Phase 1b/2a Clinical Study at the Muscular Dystrophy Association Clinical and Scientific Conference [Yahoo! Finance]
Medium
Report
Benitec Biopharma Announces Acceptance of Late- Breaking Oral Abstract for the BB-301 Phase 1b/2a Clinical Study at the Muscular Dystrophy Association Clinical and Scientific Conference [Yahoo! Finance]
2/14
09:15 am
bntc
Benitec Biopharma Releases Second Quarter 2025 Financial Results and Provides Operational Update [Yahoo! Finance]
Medium
Report
Benitec Biopharma Releases Second Quarter 2025 Financial Results and Provides Operational Update [Yahoo! Finance]
2/14
08:10 am
bntc
Benitec Biopharma Releases Second Quarter 2025 Financial Results and Provides Operational Update
High
Report
Benitec Biopharma Releases Second Quarter 2025 Financial Results and Provides Operational Update
2/14
08:00 am
bntc
Benitec Biopharma Announces Acceptance of Late- Breaking Oral Abstract for the BB-301 Phase 1b/2a Clinical Study at the Muscular Dystrophy Association Clinical and Scientific Conference
High
Report
Benitec Biopharma Announces Acceptance of Late- Breaking Oral Abstract for the BB-301 Phase 1b/2a Clinical Study at the Muscular Dystrophy Association Clinical and Scientific Conference
1/27
08:00 am
bntc
Benitec Biopharma to Participate in Upcoming Conferences in January and February
Low
Report
Benitec Biopharma to Participate in Upcoming Conferences in January and February
12/18
10:43 am
bntc
Hedge funds investors own a significant stake of 38% in Benitec Biopharma Inc. (NASDAQ:BNTC) [Yahoo! Finance]
Medium
Report
Hedge funds investors own a significant stake of 38% in Benitec Biopharma Inc. (NASDAQ:BNTC) [Yahoo! Finance]
12/17
06:28 am
bntc
Benitec Biopharma Inc. (NASDAQ: BNTC) was upgraded by analysts at Baird R W to a "strong-buy" rating.
Low
Report
Benitec Biopharma Inc. (NASDAQ: BNTC) was upgraded by analysts at Baird R W to a "strong-buy" rating.
12/16
07:05 am
bntc
Benitec Biopharma Inc. (NASDAQ: BNTC) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $28.00 price target on the stock.
Medium
Report
Benitec Biopharma Inc. (NASDAQ: BNTC) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $28.00 price target on the stock.
12/16
07:05 am
bntc
Benitec Biopharma Inc. (NASDAQ: BNTC) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $28.00 price target on the stock.
Medium
Report
Benitec Biopharma Inc. (NASDAQ: BNTC) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $28.00 price target on the stock.
12/13
07:49 am
bntc
Benitec Biopharma Inc. (NASDAQ: BNTC) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $30.00 price target on the stock.
Medium
Report
Benitec Biopharma Inc. (NASDAQ: BNTC) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $30.00 price target on the stock.
12/9
11:58 am
bntc
Wall Street Analysts See an 113.71% Upside in Benitec Biopharma (BNTC): Can the Stock Really Move This High? [Yahoo! Finance]
Low
Report
Wall Street Analysts See an 113.71% Upside in Benitec Biopharma (BNTC): Can the Stock Really Move This High? [Yahoo! Finance]
12/9
10:49 am
bntc
Benitec Biopharma (BNTC) Is a Great Choice for 'Trend' Investors, Here's Why [Yahoo! Finance]
Medium
Report
Benitec Biopharma (BNTC) Is a Great Choice for 'Trend' Investors, Here's Why [Yahoo! Finance]
12/3
11:45 am
bntc
Benitec Biopharma Inc. (NASDAQ: BNTC) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $17.00 price target on the stock.
Neutral
Report
Benitec Biopharma Inc. (NASDAQ: BNTC) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $17.00 price target on the stock.
11/26
07:00 am
bntc
Benitec Biopharma to Participate in Upcoming Investor Conferences in December
Low
Report
Benitec Biopharma to Participate in Upcoming Investor Conferences in December